HNPCC患者错配修复基因转录调控因子作用分析

批准号:
39970823
项目类别:
面上项目
资助金额:
15.0 万元
负责人:
崔龙
依托单位:
学科分类:
H1801.肿瘤病因
结题年份:
2002
批准年份:
1999
项目状态:
已结题
项目参与者:
高军、金国祥、喻德洪、于恩达、程慧玉、王汉寿、谷爱梅、黄海、龙建秋
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
从典型及不典型HNPCC患者肿瘤组织及正常淋巴细胞中提取基因组DNA,PCR-SSCP法检测6种MMR基因突变。选择无MMR编码区变异的患者,PCR法克隆其正常组织及肿瘤组织MMR基因启动有蛄胁⒓右员冉希奔觳庹W橹爸琢鲎橹疨53基因的变异。构建由该启动子调控报告基因的载体并分别将其转染至P53基因正常及异常的肿瘤细胞系,检测报告基因活性以分析寺⌒蛄蠵53蛋白的结合作用,为进一步阐明HNPCC的发病机理及临床诊断奠定基础。
英文摘要
In this study,we collected and followed up 50 typical and nontypical HNPCC kindreds.The clinicopthological features of the Chinese HNPCC were study and a new criteria of the nontypical HNPCC was defined and its clinical significence was studies.The germline mutation of hMLH1 and hMSH2 of 12 index cases of 6 nontypical HNPCC and 6 typical HNPCC were study using PCR-SSCP and sequencing. Senven germline mutations in 6 cases were found. Especially,one case had the germline mution of hMLH1 and hMSH2 spontanously.The expression of hMLH1 and hMSH2 were analysed with immunohistochemistry method. We also study the significant of MSI in screening the HNPCC families . The promoter of hMLH1 and hMSH2 were studied in our program.We found a novel germline mutation in one cases. The P53 mutaion was exclusive from the germline mutaion of hMLH1 and hMSH2,which might imply a new path of HNPCC carcinogenesis.
专著列表
科研奖励列表
会议论文列表
专利列表
GALNT3甲基化调控Mucin1糖基化修饰对喉癌转移的作用机制
- 批准号:81301827
- 项目类别:青年科学基金项目
- 资助金额:23.0万元
- 批准年份:2013
- 负责人:崔龙
- 依托单位:
HNPCC转基因鼠模型建立及抑制其肠道肿瘤形成研究
- 批准号:30170927
- 项目类别:面上项目
- 资助金额:19.0万元
- 批准年份:2001
- 负责人:崔龙
- 依托单位:
CEA转录调控序列的克隆及其在大肠癌基因治疗中的应用
- 批准号:39600142
- 项目类别:青年科学基金项目
- 资助金额:9.0万元
- 批准年份:1996
- 负责人:崔龙
- 依托单位:
国内基金
海外基金
